FibroGen
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $46,333 | $50,641 | $55,902 | $27,138 |
Gross Profit | 41,038 | 45,463 | 30,149 | 21,731 |
EBITDA | -12,237 | -10,138 | -27,673 | -49,824 |
EBIT | -12,976 | -10,919 | -28,493 | -51,699 |
Net Income | -17,084 | -15,544 | -32,933 | -56,232 |
Net Change In Cash | 46,333 | 50,641 | 55,902 | 27,138 |
Free Cash Flow | -8,458 | -39,883 | -59,317 | -18,572 |
Cash | 131,003 | 140,714 | 105,734 | 113,688 |
Basic Shares | 100,515 | 99,835 | 98,982 | 98,496 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $147,752 | $140,734 | $235,309 | $176,319 |
Gross Profit | 128,904 | 120,454 | 222,438 | 167,450 |
EBITDA | -261,405 | -282,825 | -273,721 | -164,280 |
EBIT | -271,335 | -293,429 | -288,530 | -186,327 |
Net Income | -284,232 | -295,227 | -291,030 | -189,291 |
Net Change In Cash | 147,752 | 140,734 | 235,309 | 176,319 |
Cost of Revenue | -509,767 | 547,432 | ||
Free Cash Flow | -317,540 | -184,674 | -112,418 | 77,608 |
Cash | 113,688 | 155,700 | 171,223 | 678,393 |
Basic Shares | 97,303 | 93,582 | 92,349 | 89,854 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.01 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.33 |
2023-12-31 | -$0.57 |
